41 research outputs found
Possibilities of Utilizing Dietary Supplements in Semi-intensive Culture of Deccan Mahseer, Tor khudree (Sykes)
Effect of Feeding Frequency on Growth Performance, Feed Efficiency and Bioenergetics of Golden Mahseer Early Fry
Not Available
Not AvailableIn the upland regions of India, the indigenous golden mahseer Tor putitora (Hamilton), is well recognized as one of the important game as well as food fish and for that reason in commercial fisheries too, it should occupy an important position. In the past, there has been a great decline in the fishery of golden mahseer and is now feared to be endangered. Thus, development of fisheries of this fish in impoundment waters will play a significant role in economy of the country because high mortality is associated with first feeding of golden mahseer in controlled conditions of hatchery. To enhance the growth of golden mahseer under culture systems, it becomes necessary to know about its feeding regime. Feed accounts major portion of the cost of fish culture system. A trial was conducted, to establish optimum feeding frequency, for rearing early fry of golden mahseer. The influence of feeding frequency on survival, growth performance, feed efficiency, protein efficiency ratio (PER), meal size and bioenergetic parameters was studied in the early fry of golden mahseer. Fish were stocked in tanks with flow through water system keeping three replicates for each treatment. Feeding was carried out four times a day, three times a day, two times a day and once a day for a period of 45 days. Frequency of feeding was found to significantly influence the growth parameters, feed efficiency, meal size and the bioenergetic parameters. Net weight gain, percent weight gain and specific growth rate (SGR) were significantly higher (p < 0.05) in fish fed three times a day than those fed one, two and four times a day. Feed conversion ratio (FCR), feed conversion efficiency (FCE) and PER were significantly better (p < 0.05) in fish fed three and four times a day compared with those fed one and two times a day. Meal size of 70% was significantly higher (p < 0.05) for fish fed three times a day compared to those fed one, two and four times a day. Fish fed three times a day had higher feeding rate 148.93 Jg-1.day-1, absorption rate 142.12 Jg-1.day-1 and absorption efficiency 95.43 Jg-1.day-1 compared with those fed with all other feeding frequencies. However, the percentage survival was independent of the treatments. This suggests that the best feeding frequency for golden mahseer early fry is three times a day.Indian Council of Agricultural Research (ICAR
Optimum patient selection for irinotecan-containing regimens in metastatic colorectal cancer: Literature review and lessons from clinical practice
Effects of Available Diets with Different Protein to Energy Ratios on Growth, Nutrient Utilization and Body Composition of Juvenile Himalayan Golden Mahseer, Tor putitora (Hamilton)
Genomic assays in breast cancer: Issues yet to settle?
<p>Breast cancer today has emerged as the most commonly diagnosed malignancy in women world wide, accounting for 1 in 4 of every cancer diagnosed in women today. It is the leading cause of cancer death in women in the developing world and second leading cause of cancer (following lung cancer) in the developed world. Introduction of novel high through-output gene expression profiling technologies such as Next Generation Sequencing (NGS) and Genome wide association studies (GWAS) has led to the genetic profiling of breast cancer and to the development of genomic assays that ushered in an paradigm shift in the management of breast cancer from single individual variable to multivariate prediction models encompassing the tumors gross, microscopic and genetic variables. Oncotype DX, MammaPrint assay, MammoStrat assay, &amp; Prosigna kit are some of the commercially available assays in various stages of validation. But various studies have reported discordance in risk stratification when the different tests is applied to the same patient cohort leading to a therapeutic quagmire. Tumor genetic signatures are not concordant but highly variable with each carrying its own unique set of genes dictating its growth, response to chemotherapy and risk of recurrence. Similarly triple negative breast cancers (TNBC), risk of late recurrence (&gt; 5 years), validity of these over different population groups and quality control are some of the other issues which are yet to settle.</p></jats:p
